BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Holistic medicine
,
Valproic acid
,
rs3825942
,
FOXP1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vegf) inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
Umbilical vein endothelial cells with S100A6 siRNA knockdown, with or without VEGF-A treatment
Breast tumors after addition of multikinase inhibitor sorafenib to existing endocrine therapy
Glioblastoma U-87 MG xenografts treated with bevacizumab or dibenzazepine
U87 glioblastoma xenografts treated with bevacizumab or dibenzazepine
Sarcoma gene expression in tumors with good and poor responses to bevacizumab treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in viv…
Vascular endothelial growth factor pathway promotes osseointegration and CD31hiEMCNhi endothelium ex…
Vitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dr…
Curcumin stimulates angiogenesis through VEGF and expression of HLA-G in first-trimester human place…
Biodegradable magnesium combined with distraction osteogenesis synergistically stimulates bone tissu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer
Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associate…
PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ